Revenue vs Net income
Reported dollars from 10-Q / 10-K filings. Q4 bars are derived (annual less nine months) where the 10-K does not tag Q4 separately.
Margin trend
Gross, operating and net margin. Margins are derived from reported dollars.
Revenue YoY growth
Year-over-year change vs the same quarter (or fiscal year) a year earlier. Shown where the prior-year period is in the 8-quarter snapshot (latest four quarters).
Income statement
From 10-Q / 10-K XBRL. Values in reported dollars; EPS in $/share; share counts in shares.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4B | $13.5B | $12.7B | $15.6B | $17.6B | $19.3B | $19.8B | $23.0B |
| YoY | — | — | — | — | +53.9% | +42.6% | +55.5% | +47.7% |
| Cost of goods sold | $2.2B | $2.4B | $2.2B | $2.4B | $3.0B | $3.4B | $3.6B | $3.3B |
| YoY | — | — | — | — | +38.6% | +40.3% | +60.8% | +33.5% |
| Gross profit | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Research & development | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Selling, general & administrative | $2.1B | $2.4B | $2.5B | $2.8B | $2.7B | $3.1B | $2.9B | $3.4B |
| YoY | — | — | — | — | +30.5% | +29.1% | +18.9% | +24.6% |
| Operating income | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Pretax income | $1.6B | $5.0B | $3.5B | $6.8B | $7.2B | $8.3B | $8.8B | $9.2B |
| YoY | — | — | — | — | +355.3% | +64.1% | +156.1% | +36.4% |
| Income tax | $618.1M | $628.5M | $697.0M | $1.1B | $1.6B | $1.6B | $1.5B | $2.2B |
| YoY | — | — | — | — | +166.9% | +159.1% | +108.6% | +92.8% |
| Net income | $970.3M | $4.4B | $2.8B | $5.7B | $5.6B | $6.6B | $7.4B | $7.1B |
| YoY | — | — | — | — | +475.3% | +50.5% | +168.1% | +25.3% |
| EPS — basic | $1.08 | — | $3.07 | $6.30 | $6.22 | — | $8.27 | $7.95 |
| YoY | — | — | — | — | +475.9% | — | +169.4% | +26.2% |
| EPS — diluted | $1.07 | — | $3.06 | $6.29 | $6.21 | — | $8.26 | $7.94 |
| YoY | — | — | — | — | +480.4% | — | +169.9% | +26.2% |
| Weighted shares — basic | 901.0M | — | 898.7M | 897.9M | 896.9M | — | 894.5M | 892.4M |
| Weighted shares — diluted | 905.0M | — | 900.6M | 899.8M | 898.8M | — | 895.9M | 893.7M |
Balance sheet
Point-in-time values at each quarter (or fiscal year) end.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.4B | $3.3B | $3.1B | $3.4B | $9.8B | $7.3B | $5.3B | $8.9B |
| YoY | — | — | — | — | +190.6% | +122.4% | +70.8% | +165.1% |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Accounts receivable | $10.3B | $11.0B | $12.0B | $14.2B | $16.1B | $17.8B | $18.4B | $20.1B |
| YoY | — | — | — | — | +56.5% | +61.4% | +53.1% | +41.7% |
| Inventory | $7.5B | $7.6B | $9.3B | $11.0B | $12.2B | $13.7B | $14.5B | $16.8B |
| YoY | — | — | — | — | +63.3% | +81.1% | +56.0% | +52.5% |
| Total current assets | $31.4B | $32.7B | $41.3B | $49.9B | $62.1B | $55.6B | $54.8B | $64.7B |
| YoY | — | — | — | — | +97.6% | +69.9% | +32.9% | +29.7% |
| Total assets | $75.6B | $78.7B | $89.4B | $100.9B | $114.9B | $112.5B | $116.6B | $142.3B |
| YoY | — | — | — | — | +52.0% | +42.9% | +30.4% | +41.0% |
| Total current liabilities | $24.7B | $28.4B | $30.1B | $39.0B | $40.1B | $35.2B | $36.6B | $47.7B |
| YoY | — | — | — | — | +62.7% | +24.1% | +21.8% | +22.4% |
| Total liabilities | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Total equity | $14.2B | $14.3B | $15.8B | $18.3B | $23.8B | $26.5B | $31.2B | $33.9B |
| YoY | — | — | — | — | +67.1% | +85.9% | +97.9% | +85.4% |
| Shares outstanding | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
Cash flow
Quarterly values derived from year-to-date filings (Q4 from the 10-K). Free cash flow = operating cash flow − capital expenditures.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.7B | $2.5B | $1.7B | $3.1B | $8.8B | $3.2B | $5.3B | $10.7B |
| YoY | — | — | — | — | +138.0% | +30.3% | +220.1% | +246.3% |
| Capital expenditures | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Dividends paid | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | $1.5B | $1.5B |
| YoY | — | — | — | — | +15.0% | +15.2% | +15.0% | +14.8% |
| Share repurchases | $446.1M | $2.1B | $1.2B | $692.0M | $708.3M | $1.5B | $2.4B | $1.6B |
| YoY | — | — | — | — | +58.8% | -26.6% | +96.3% | +131.4% |
Margins & ratios
Derived from the reported dollars above — no separate source.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | 8.5% | 32.6% | 21.7% | 36.4% | 31.7% | 34.4% | 37.4% | 30.9% |
| Free cash flow margin | — | — | — | — | — | — | — | — |
| Effective tax rate | 38.9% | 12.5% | 20.2% | 16.5% | 22.8% | 19.7% | 16.4% | 23.3% |
| Current ratio | 1.27x | 1.15x | 1.37x | 1.28x | 1.55x | 1.58x | 1.50x | 1.35x |
| Total liabilities / equity | — | — | — | — | — | — | — | — |
Peer comparison — latest full year
Same sector (Health Care), sorted by revenue. All figures from the same EDGAR XBRL snapshot.
| Ticker | Revenue | Revenue YoY | Gross margin | Operating margin | Net margin | FCF margin |
|---|---|---|---|---|---|---|
| LLY FY25 · this stock | $65.2B | +44.7% | — | — | 31.7% | — |
| UNH FY25 | $447.6B | +11.8% | — | 4.2% | 2.7% | 3.6% |
| CVS FY25 | $402.1B | +7.8% | — | 1.2% | 0.4% | 1.9% |
| CI FY25 | $274.9B | +11.2% | — | 3.3% | — | — |
| ELV FY25 | $199.1B | +12.5% | — | 3.6% | 2.8% | 1.6% |
| JNJ FY25 | $94.2B | +6.0% | 67.9% | — | 28.5% | 20.9% |
| MRK FY25 | $65.0B | +1.3% | — | — | 28.1% | 19.0% |
| ABBV FY25 | $61.2B | +8.6% | — | 24.6% | 6.9% | 29.1% |
| BMY FY25 | $48.2B | -0.2% | — | — | 14.6% | 26.7% |
| TMO FY25 | $44.6B | +3.9% | — | 17.4% | 15.0% | 14.1% |
| ABT FY25 | $44.3B | +5.7% | — | 18.2% | 14.7% | 16.7% |
Source: SEC EDGAR XBRL company facts (10-Q / 10-K), snapshot generated 2026-11-03 for 218 tickers. Q4 values are derived as the 10-K annual less the first nine months, since Q4 is not separately tagged in company facts; cash-flow quarterly values are derived from year-to-date filings the same way. Free cash flow = operating cash flow − capital expenditures. Blank cells mean the filing does not report that line item under a standard US-GAAP tag — nothing is estimated or filled in. Descriptive research, not investment advice. How EarnIQ builds fundamentals.